CHER—52

Chemkart India Ltd

Miscellaneous Specialty RetailersVerified

Score breakdown

Profitability+35Sentiment+30Risk penalty-3Missing signals-3

Quality breakdown

Key fields100Profile38Conclusion95AI synthesis20Observations3

Chemkart India operates with a debt-to-equity ratio of 0.32 and a current ratio of 2.36, indicating a relatively strong liquidity position despite a negative cash balance of INR 1 million [doc:HA-latest]. The company's return on equity of 45.55% and return on assets of 28.18% suggest strong profitability relative to its equity and asset base [doc:HA-latest]. The company's operating income of INR 322.33 million and net income of INR 242.71 million reflect a healthy margin performance, though specific comparisons to industry medians are not available in the provided data [doc:HA-latest]. The gross profit of INR 389.10 million indicates a solid gross margin, which is a key performance indicator for the industry [doc:HA-latest]. Chemkart's revenue is derived from a diverse range of products and services, including Vitamins, Amino Acids, Herbal Extracts, and Nutraceuticals, with no specific revenue concentration disclosed in the input data [doc:HA-latest]. The company serves multiple sectors, including pharmaceuticals, nutraceuticals, food beverages, and cosmetics, which may provide some diversification benefits [doc:HA-latest]. The company's growth trajectory is not explicitly detailed in the input data, but the operating cash flow of INR 39.69 million and free cash flow of INR 205.37 million suggest a positive cash flow generation capability [doc:HA-latest]. The capital expenditure of INR -42.51 million indicates a reduction in capital spending, which may be a strategic decision to preserve cash [doc:HA-latest]. The risk assessment indicates a medium liquidity risk and a low dilution risk, with a key flag noting that net cash is negative after subtracting total debt [doc:HA-latest]. The company's dilution potential is low, and no specific dilution sources are cited in the input data [doc:HA-latest]. Recent events and filings are not detailed in the input data, but the company's financial snapshot provides a current view of its financial health [doc:HA-latest].

Profile

CompanyChemkart India Ltd

TickerCHER.BO

SectorConsumer Cyclicals

BusinessRetailers

Industry groupRetailers

IndustryMiscellaneous Specialty Retailers

AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Key takeaways

Chemkart India has a strong return on equity and assets, indicating efficient use of capital.
The company's liquidity position is relatively strong, with a current ratio of 2.36.
Despite a negative cash balance, the company generates positive operating and free cash flows.
The company's debt-to-equity ratio is low, suggesting a conservative capital structure.
The company serves a diverse set of sectors, which may help mitigate sector-specific risks.
--
**RATIONALES**:
```json

Financial snapshot

PeriodHA-latest

CurrencyINR

Revenue$2.03B

Gross profit$389.1M

Operating income$322.3M

Net income$242.7M

R&D—

SG&A—

D&A—

SBC—

Operating cash flow$39.7M

CapEx-$42.5M

Free cash flow$205.4M

Total assets$861.2M

Total liabilities$328.3M

Total equity$532.9M

Cash & equivalents-$1.0k

Long-term debt$170.3M

Annual history (last 5)

PeriodRevenueOp IncomeNet IncomeFCF

FY0————

FY-1————

FY-2————

FY-3————

FY-4————

PeriodGross %Op %Net %FCF %

FY0————

FY-1————

FY-2————

FY-3————

FY-4————

PeriodAssetsEquityCashDebt

FY0————

FY-1————

FY-2————

FY-3————

FY-4————

PeriodOCFCapExFCFSBC

FY0————

FY-1————

FY-2————

FY-3————

FY-4————

Quarterly history (last 4)

PeriodRevenueOp IncomeNet IncomeFCF

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

PeriodGross %Op %Net %FCF %

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

PeriodAssetsEquityCashDebt

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

PeriodOCFCapExFCFSBC

FQ0————

FQ-1————

FQ-2————

FQ-3————

FQ-4————

FQ-5————

FQ-6————

FQ-7————

Valuation

Market price—

Market cap—

Enterprise value—

P/E—

Reported non-GAAP P/E—

EV/Revenue—

EV/Op income—

EV/OCF—

P/B—

P/Tangible book—

Tangible book$532.9M

Net cash-$170.3M

Current ratio2.4

Debt/Equity0.3

ROA28.2%

ROE45.6%

Cash conversion16.0%

CapEx/Revenue-2.1%

SBC/Revenue—

Asset intensity—

Dilution ratio0.0%

Risk assessment

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Industry benchmarks

Activity: Retailers · cohort 2 companies

MetricCHERActivity

Op margin15.9%20.7% medp25 18.7% · p75 22.8%bottom quartile

Net margin11.9%15.6% medp25 13.4% · p75 17.7%bottom quartile

Gross margin19.1%31.0% medp25 19.6% · p75 40.5%bottom quartile

R&D / revenue—0.4% medp25 0.4% · p75 0.4%

CapEx / revenue-2.1%4.6% medp25 3.2% · p75 5.9%bottom quartile

Debt / equity32.0%39.3% medp25 19.7% · p75 97.3%below median

Source data

Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.

Company fundamentalsperiod FQ-7 · history via verified-market-data

no public URL

2026-05-04 08:57 UTC#9339704e

Source: analysis-pipeline (hybrid)Generated: 2026-05-04 08:59 UTCJob: e334b9ec